14/12/2015 : Theradiag expands its biotherapy monitoring range, with a new CE marking obtained for its Entyvio® test
11th CE marking for the Lisa Tracker® rangeComplete range of monitoring tests for inflammatory bowel disease biotherapiesCroissy-Beaubourg and Montpellier, December 14, 2015 – THERADIAG (ISIN: FR0004197747, Ticker: ALTER), a company specialized in in vitro diagnostics…